Newamsterdam Pharma Company N.V. (NAMS)

Newamsterdam Pharma Company N.V.

NAMS

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Viking Global Investors	Equity	6,978,534	$142,850,591	0.45%	0%
Duquesne Family Office	Equity	800,360	$16,383,000	0.54%	+178.35%
Maverick Capital	Equity	549,469	$11,247,630	0.20%	+56.99%

Total Shares Held: 8,328,363

Total Value Reported: $170,481,221

Average Allocation per Portfolio 0.40%

Largest Single Portfolio Allocation: 0.54%

Largest Shareholder: Viking Global Investors

Change in Total Shares Held (Q on Q): +712,289

Percentage Change in Shares Held (Q on Q): 9.35%

Number of Current Holders: 3

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 2

Number of Funds with Deductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1